Full Schedule

Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT

Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University

Speaker: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona

Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute

Speaker: Lawrence H. Boise, PhD – Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA

Speaker: Mariateresa Fulciniti, PhD – Dana-Farber Cancer Institute

Speaker: Angela Dispenzieri, MD – Mayo Clinic Rochester

Chair: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Speaker: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Speaker: Donna E. Reece, MD (she/her/hers) – University Health Network, Princess Margaret Cancer Centre

Speaker: Craig Emmitt Cole, MD (he/him/his) – Karmanos Cancer Institute-Wayne State and Michigan State University

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Panelist: Donna E. Reece, MD (she/her/hers) – University Health Network, Princess Margaret Cancer Centre

Panelist: Craig Emmitt Cole, MD (he/him/his) – Karmanos Cancer Institute-Wayne State and Michigan State University

Panelist: Cyrille Touzeau, MD, PhD – CHU Nantes

Co-Chair: Sundar Jagannath, MD, FASCO (he/him/his) – Mount Sinai Medical Center, New York, NY, USA

Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center

Speaker: Jordan M. Schecter, MD (he/him/his) – Janssen R&D, Raritan, NJ, USA

Panelist: Jordan M. Schecter, MD (he/him/his) – Janssen R&D, Raritan, NJ, USA

Speaker: Joanna Opalinska, n/a – GlaxoSmithKline

Panelist: Joanna Opalinska, n/a – GlaxoSmithKline

Speaker: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Panelist: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Speaker: Zandra K. Klippel, MD (she/her/hers) – Sanofi

Panelist: Zandra K. Klippel, MD (she/her/hers) – Sanofi

Speaker: Isabel Perez Cruz, PhD – Pfizer

Panelist: Isabel Perez Cruz, PhD – Pfizer

Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Co-Chair: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Teng Fang, PhD student – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Speaker: Mariateresa Fulciniti, PhD – Dana-Farber Cancer Institute

Speaker: Sae Matsuoka, MD (she/her/hers) – Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan

Speaker: Paula Rodriguez-Marquez, PhD (she/her/hers) – Hemato-Oncology Program. CIMA Universidad de Navarra. IdiSNA

Co-Chair: Javier de la Rubia, Prof. Dr. (he/him/his) – Hematology Department, University Hospital La Fe

Co-Chair: Cyrille Touzeau, MD, PhD – CHU Nantes

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Neha Korde, MD – Memorial Sloan Kettering Cancer Center

Speaker: Sheeba Thomas, MD (she/her/hers) – MD Anderson Cancer Center

Speaker: Oliver M. Tomkins, MRCP FRCPath – University College London Hospitals NHS Foundation Trust

Speaker: Christopher Parrish, PhD (he/him/his) – Leeds Teaching Hospitals NHS Trust

Co-Chair: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA

Co-Chair: Brian A. Walker, PhD (he/him/his) – Indiana University

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Speaker: Shebli Atrash, MD – Levine Cancer Institute

Speaker: Abel Costa, MD – D'Or Institute for Research and Education

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Co-Chair: Damian Green, MD (he/him/his) – Sylvester Comprehensive Cancer Center/University of Miami

Co-Chair: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Speaker: Marta Larrayoz, PhD (she/her/hers) – University of Navarra

Speaker: Phaik Ju Teoh, PhD – Cancer Science Institute of Singapore, National University of Singapore

Speaker: David Fandrei, MSc – University Leipzig Medical Center, Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany

Speaker: Lixin Gong, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China. – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Speaker: Qiang Wang (he/him/his) – Houston Methodist Research Institute

Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Speaker: Ashley Rosko, MD (she/her/hers) – The Ohio State University

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)

Panelist: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Panelist: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Panelist: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Panelist: Ashley Rosko, MD (she/her/hers) – The Ohio State University